NR4A1 and breast cancer: Despite the above progress in preclinical models, little is known about the importance of α3β1 within different breast cancer subtypes, or whether α3β1 expression is correlated to clinical diagnostic characteristics such as hormone receptor status, tumor stage, or metastasis.